NantHealth Inc (NH) Lifted to Sell at BidaskClub

BidaskClub upgraded shares of NantHealth Inc (NYSE:NH) from a strong sell rating to a sell rating in a research note published on Friday.

A number of other equities analysts have also weighed in on the stock. Jefferies Group LLC restated a buy rating and set a $5.50 target price (down previously from $8.00) on shares of NantHealth in a research report on Monday, June 19th. Canaccord Genuity restated a buy rating and set a $6.00 target price (down previously from $8.00) on shares of NantHealth in a research report on Monday, August 21st. One research analyst has rated the stock with a sell rating and five have given a buy rating to the stock. The stock has a consensus rating of Buy and an average target price of $8.55.

Shares of NantHealth (NYSE NH) opened at 4.12 on Friday. The stock’s 50 day moving average is $3.60 and its 200-day moving average is $4.13. NantHealth has a 12-month low of $2.60 and a 12-month high of $15.80. The company’s market capitalization is $502.42 million.

NantHealth (NYSE:NH) last issued its earnings results on Thursday, August 10th. The company reported ($0.58) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.26) by $0.32. NantHealth had a negative return on equity of 83.97% and a negative net margin of 267.11%. The company had revenue of $26.23 million for the quarter, compared to the consensus estimate of $31.28 million. During the same quarter in the prior year, the company posted ($0.15) EPS. NantHealth’s revenue was down 16.7% compared to the same quarter last year. Analysts anticipate that NantHealth will post ($0.70) earnings per share for the current year.

WARNING: This story was reported by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this story on another website, it was copied illegally and reposted in violation of US and international copyright & trademark legislation. The original version of this story can be accessed at https://sportsperspectives.com/2017/09/11/nanthealth-inc-nh-lifted-to-sell-at-bidaskclub.html.

A number of hedge funds have recently added to or reduced their stakes in the business. TIAA CREF Investment Management LLC lifted its position in NantHealth by 68.6% during the first quarter. TIAA CREF Investment Management LLC now owns 20,200 shares of the company’s stock valued at $100,000 after purchasing an additional 8,217 shares during the last quarter. California State Teachers Retirement System lifted its position in NantHealth by 132.4% during the second quarter. California State Teachers Retirement System now owns 31,600 shares of the company’s stock valued at $134,000 after purchasing an additional 18,000 shares during the last quarter. Bank of America Corp DE lifted its position in NantHealth by 366.4% during the first quarter. Bank of America Corp DE now owns 25,069 shares of the company’s stock valued at $125,000 after purchasing an additional 19,694 shares during the last quarter. Alliancebernstein L.P. bought a new position in NantHealth during the second quarter valued at $102,000. Finally, Teachers Advisors LLC lifted its position in NantHealth by 351.8% during the second quarter. Teachers Advisors LLC now owns 31,578 shares of the company’s stock valued at $134,000 after purchasing an additional 24,588 shares during the last quarter.

NantHealth Company Profile

NantHealth, Inc is a healthcare cloud-based information technology (IT) company. The Company is engaged in converging science and technology through a single integrated clinical platform, to provide actionable health information at the point of care. The Company offers the Genomic Proteomic Spectrometry (GPS) Cancer test, a molecular test and decision support solution that measures the proteins present in the patient’s tumor tissue, combined with whole genomic and transcriptomic sequencing of tumor and normal samples.

Receive News & Ratings for NantHealth Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantHealth Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply